Werkgroep Cardiologische centra Nederland

METEORIC-HF (Recruiting)

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction and Decreased Exercise Tolerance
Medicine
Omecamtiv Mecarbil
Population
Heart failure
Phase
III
Starting year
2018
More information
Clinicaltrials.gov